**Core Concept**
Pulmonary hypertension (PH) is a progressive disease characterized by elevated pulmonary artery pressure, leading to right ventricular failure and decreased exercise tolerance. Treatment aims to reduce pulmonary vascular resistance, improve right ventricular function, and enhance quality of life.

**Why the Correct Answer is Right**
The management of PH involves a multi-modal approach, including pharmacological therapy, pulmonary rehabilitation, and in some cases, lung transplantation. The correct answer is a treatment that is not typically used for PH.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Bosentan, an endothelin receptor antagonist, is actually used in the treatment of pulmonary hypertension to reduce pulmonary vascular resistance.
* **Option B:** This option is incorrect because Phosphodiesterase-5 inhibitors, such as Sildenafil, are used to treat pulmonary hypertension by relaxing pulmonary vascular smooth muscle and reducing pulmonary artery pressure.
* **Option C:** This option is incorrect because Prostacyclin analogs, such as Epoprostenol, are used to treat pulmonary hypertension by inhibiting platelet activation and aggregation, and reducing pulmonary vascular resistance.

**Clinical Pearl / High-Yield Fact**
In patients with pulmonary hypertension, the use of calcium channel blockers can unmask and differentiate between reactive pulmonary hypertension and idiopathic pulmonary hypertension.

**Correct Answer: D. This option is not specified, but it is likely a treatment that is not used for pulmonary hypertension.**